Rockwell Medical (RMTI) Research & Development (2010 - 2024)

Rockwell Medical has reported Research & Development for 15 years, with the latest figure at $1000.0 in Q4 2024.

• For the quarter ending Q4 2024, Research & Development fell 99.4% year-over-year to $1000.0; the trailing twelve-month figure through Sep 2025 stood at $1000.0 (down 99.46% YoY), and the FY2024 full-year result was $19000.0, down 98.28% from the prior year.
• Research & Development for Q4 2024 stood at $1000.0, down from $18000.0 in the prior quarter.
• The five-year high for Research & Development was $2.4 million in Q2 2021, with the low at $1000.0 in Q4 2024.
• Historically, Research & Development has averaged $1.0 million across 5 years, with a median of $1.1 million in 2021.
• Annual changes were most pronounced in 2020 — Research & Development soared 266.4% — and 2024, when it tumbled 99.4%.
• Rockwell Medical's Research & Development stood at $1.9 million in 2020, then decreased by 29.02% to $1.4 million in 2021, then slumped by 89.89% to $137000.0 in 2022, then increased by 22.63% to $168000.0 in 2023, then plunged by 99.4% to $1000.0 in 2024.
• The last three Research & Development figures came in at $1000.0 (Q4 2024), $18000.0 (Q1 2024), and $168000.0 (Q4 2023), per Business Quant data.